BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24628360)

  • 1. Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.
    Feduccia AA; Simms JA; Mill D; Yi HY; Bartlett SE
    Br J Pharmacol; 2014 Jul; 171(14):3420-31. PubMed ID: 24628360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptors in the anterior, but not posterior, ventral tegmental area mediate ethanol-induced elevation of accumbal dopamine levels.
    Ericson M; Löf E; Stomberg R; Chau P; Söderpalm B
    J Pharmacol Exp Ther; 2008 Jul; 326(1):76-82. PubMed ID: 18369179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors.
    Schilaty ND; Hedges DM; Jang EY; Folsom RJ; Yorgason JT; McIntosh JM; Steffensen SC
    J Pharmacol Exp Ther; 2014 Jun; 349(3):559-67. PubMed ID: 24643637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
    Hendrickson LM; Zhao-Shea R; Pang X; Gardner PD; Tapper AR
    J Neurosci; 2010 Jul; 30(30):10169-76. PubMed ID: 20668200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core.
    Wickham R; Solecki W; Rathbun L; McIntosh JM; Addy NA
    Psychopharmacology (Berl); 2013 Sep; 229(1):73-82. PubMed ID: 23624852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Kamens HM; Andersen J; Picciotto MR
    Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.
    Ericson M; Molander A; Löf E; Engel JA; Söderpalm B
    Eur J Pharmacol; 2003 Apr; 467(1-3):85-93. PubMed ID: 12706460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.
    Chau P; Höifödt-Lidö H; Löf E; Söderpalm B; Ericson M
    Alcohol Clin Exp Res; 2010 Jan; 34(1):39-45. PubMed ID: 19860809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
    Ericson M; Löf E; Stomberg R; Söderpalm B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):225-30. PubMed ID: 19126781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acetylcholine-dopamine interaction in the nucleus accumbens and its involvement in ethanol's dopamine-releasing effect.
    Loftén A; Adermark L; Ericson M; Söderpalm B
    Addict Biol; 2021 May; 26(3):e12959. PubMed ID: 32789970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
    Sotomayor-Zárate R; Gysling K; Busto UE; Cassels BK; Tampier L; Quintanilla ME
    Psychopharmacology (Berl); 2013 May; 227(2):287-98. PubMed ID: 23344555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of α6-Nicotinic Receptors in Alcohol-Induced GABAergic Synaptic Transmission and Plasticity to Cholinergic Interneurons in the Nucleus Accumbens.
    Wadsworth HA; Anderson EQ; Williams BM; Ronström JW; Moen JK; Lee AM; McIntosh JM; Wu J; Yorgason JT; Steffensen SC
    Mol Neurobiol; 2023 Jun; 60(6):3113-3129. PubMed ID: 36802012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine.
    Ericson M; Blomqvist O; Engel JA; Söderpalm B
    Eur J Pharmacol; 1998 Oct; 358(3):189-96. PubMed ID: 9822883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats.
    Söderpalm B; Danielsson K; de Bejczy A; Adermark L; Ericson M
    Addict Biol; 2020 Sep; 25(5):e12807. PubMed ID: 31293045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters.
    Williams BM; Steed ND; Woolley JT; Moedl AA; Nelson CA; Jones GC; Burris MD; Arias HR; Kim OH; Jang EY; Hone AJ; McIntosh JM; Yorgason JT; Steffensen SC
    ACS Chem Neurosci; 2024 May; 15(9):1738-1754. PubMed ID: 38613458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.
    Reperant C; Pons S; Dufour E; Rollema H; Gardier AM; Maskos U
    Neuropharmacology; 2010 Feb; 58(2):346-50. PubMed ID: 19887076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive Modulation of Dopamine Release in the Nucleus Accumbens Shell Mediated by Dopamine and Acetylcholine Receptors.
    Shin JH; Adrover MF; Alvarez VA
    J Neurosci; 2017 Nov; 37(46):11166-11180. PubMed ID: 29030431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different adaptations of dopamine release in Nucleus Accumbens shell and core of individual alcohol drinking groups of mice.
    Liu Y; Montgomery SE; Juarez B; Morel C; Zhang S; Kong Y; Calipari ES; Nestler EJ; Zhang L; Han MH
    Neuropharmacology; 2020 Sep; 175():108176. PubMed ID: 32497591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.